Stay updated on Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T17:24:17.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T18:52:33.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page, replacing the expected study record content. This blocks access to the trial details and related navigation.
    Difference
    17%
    Check dated 2026-09-19T22:21:05.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Adds the NIH grant/contract year 2016 and updates the document revision to v3.6.6 in the study record.
    Difference
    0.0%
    Check dated 2026-08-29T18:35:46.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    A new 'Revision: v3.6.5' label was added; the 'Plain Language Summary' section was removed, and the prior 'Revision: v3.6.4' reference was removed.
    Difference
    0.0%
    Check dated 2026-08-08T09:37:37.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    The page’s revision has been updated from v3.6.3 to v3.6.4, indicating a minor metadata update to the page. This does not correspond to changes in study information or functionality but reflects an updated documentation version.
    Difference
    0.0%
    Check dated 2026-07-25T01:03:13.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.